2022/3, Trimester 1, FACE-TO-FACE, Edinburgh Napier University
VIEW FULL DETAILS
Occurrence: | 001 |
Primary mode of delivery: | FACE-TO-FACE |
Location of delivery: | SIGHTHILL |
Partner: | Edinburgh Napier University |
Member of staff responsible for delivering module: | David Mincher |
Module Organiser: | |
Learning, Teaching and Assessment (LTA) Approach: |
Lectures cover LOs 1, 2, 4, 5. Tutorials and workshops cover LOs 1 – 5. Lectures will afford students with central information and present contemporary examples of scientific practices in the pharmaceutical industry and stimulate interest and independent learning activities. Guest lecturers will give further insights into key factors supporting the development of new pharmaceuticals (LO5). Proprietary drug design software will be used as a teaching tool and in student-centred learning activities.Workshop group exercises are designed to simulate methodology used in the pharmaceutical industry and, in conjunction with the tutorial programme allow students the opportunity to solve problems individually and in team exercises. IT skills and software competence, critical thinking and critical appraisal, communication and organisational skills are systemically embedded. Assessments and case studies address scientific writing, data analysis and presentation as individual pieces of work or as a team exercise. The module is designed to emphasize that progress in drug design is intrinsically research-driven. The module is delivered by research-aware and research-active staff, supported by industry-based research expertise. Students are given instruction on Literature searching; database mining and directed research article reading and evaluation. Students will be made aware of and encouraged to consider the commonality and specific differences in the execution of drug design, drug synthesis and manufacture and codes of practice between the UK and Europe and other countries including the USA and other major pharmaceutical markets which are important for those working in what is intrinsically a global industry.The module is supported by a VLE (Moodle) which is used to provide class materials (including lectures, tutorials, and workshops), resources such as animations, videos, direct links to relevant web-based resources, e:submission of coursework, self-assessment tests, interactive teaching resources, and independent study materials to cover expected prior-learning.
|
Provision is made for formative feedback in the tutorials and practical workshop group sessions in which simulated drug development problems are solved using a combination of data analysis, case study, molecular modelling and allied software applications; mechanisms are built in that allow time for reflection and revision of solutions to problems, presentation of findings and peer contributions (LO2 , LO3). Feedforward examples to support the review article assessment are also provided.
|
Summative assessment is provided for in a class test (LOs 1, 2, 4 & 5) and by a (written) review article (Monitor Article) (LOs 1, 3, 4) in which the student critically reviews (to publication standards) the current status, design and development of agents directed to selected disease states, in which there is demonstrated extensive literature survey.
|
Student Activity (Notional Equivalent Study Hours (NESH)) |
Mode of activity | Learning & Teaching Activity | NESH (Study Hours) |
Face To Face | Lecture | 30 |
Face To Face | Tutorial | 9 |
Independent Learning | Guided independent study | 161 |
| Total Study Hours | 200 |
| Expected Total Study Hours for Module | 200 |
Assessment |
Type of Assessment | Weighting % | LOs covered | Week due | Length in Hours/Words |
Report | 50 | 1,3,4 | 9 | HOURS= 0, WORDS= 2500 |
Class Test | 50 | 1, 2, 4 & 5 | 13 | HOURS= 2.5, WORDS= 0 |
Component 1 subtotal: | 50 | |
Component 2 subtotal: | 50 | | | |
Module subtotal: | 100 | | | |